- Regeneron Pharmaceuticals (REGN, Financial) to announce Q2 2025 results on August 1, 2025.
- Conference call and webcast scheduled at 8:30 AM Eastern Time.
- Earnings call replay accessible for 30 days on the company's website.
Regeneron Pharmaceuticals, Inc. (REGN) has scheduled the announcement of its second-quarter 2025 financial and operating results for Friday, August 1, 2025, prior to the opening of U.S. financial markets. A conference call and simultaneous webcast will be held at 8:30 AM Eastern Time on the same day.
Investors can access the conference call live via a webcast on the 'Investors and Media' page of Regeneron's website. For telephone participation, registration is required to receive the dial-in details. Following the event, a replay and transcript of the conference call will be made available on the company’s website for at least 30 days.
Regeneron Pharmaceuticals is a prominent biotechnology firm dedicated to inventing and commercializing life-transforming medicines. The company leverages proprietary technologies such as VelociSuite® and insights from the Regeneron Genetics Center® to accelerate drug development and address a wide range of diseases, including eye diseases, cancer, and infectious diseases.